newsfilter
← Latest News
Business Wire·

Xencor Announces Upcoming Change to Board of Directors

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and other serious diseases, today announced that Dagmar Rosa-Bjorkeson has informed the